Scorecard · Example A
Placeholder for a company Scorecard: thesis, valuation range, key assumptions, invalidation conditions, review date, status.
01
Is a company worth its price? Theses with a valuation range, invalidation conditions, and a review date.
Explore02
Does a signal hold outside its sample? Signals tested on data they were not built on.
Explore03
Will a trial meet its primary endpoint? Probabilities recorded before the readout and scored after it.
ExplorePublications
Placeholder for a company Scorecard: thesis, valuation range, key assumptions, invalidation conditions, review date, status.
Placeholder for a company Scorecard: thesis, valuation range, key assumptions, invalidation conditions, review date, status.
Placeholder for a healthcare company Scorecard whose valuation uses trial probabilities from Clinical Evidence Research.
A sector study on digital infrastructure: data center consolidation, financing, power constraints, permitting, and the EMEA market.
Placeholder for an Alpha Note: signal definition, rationale, registered test design, in-sample and out-of-sample results after costs, status.
Placeholder for an Alpha Note: signal definition, rationale, registered test design, in-sample and out-of-sample results after costs, status.
Placeholder for an Alpha Note on clinical readouts as market events, using resolved estimates from Clinical Evidence Research.
An Alpha Research Note on a reversal signal that trades price dislocations from VWAP when volume confirms them: construction, logic, and test context.
How a signal moves from discovery through factor evidence and backtesting to a portfolio.
How often registered Phase 3 trials meet their primary endpoint, by therapeutic area and trial design. The reference point for every estimate in CE-2.
Probabilities for upcoming trial readouts, recorded before the result is public and scored against the CE-1 base rate.
Why a trading signal is a claim about conditional expected return, and why only out-of-sample stability can confirm it.